FGEN logo

FibroGen (FGEN)

Profile

Full Name

FibroGen, Inc.

Ticker Symbol

FGEN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

November 14, 2014

Indexes

Not included

Website

http://www.fibrogen.com

Employees

225

Key Details

Price

$0.28(-6.22%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$29.62M(-36.71% YoY)

Annual EPS

-$0.48(+83.56% YoY)

PE ratio

-

Next earnings date

May 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.28
FGEN price is $0.28

30-Day Relative Volume

0.33
FGEN 30-day relative volume is 0.33

Price Performance

Price Most recent change

-6.22%
FGEN price was down -6.22% on Apr 16, 2025

Price YTD change

-47.62%
FGEN price is down -47.62% since January 1st

Price 1-year change

-78.65%
FGEN price is down -78.65% year-on-year

Price 3-year change

-97.65%
FGEN price is down -97.65% over the past 3 years

Price Range

Price All-time high

$68.55
FGEN price is currently -99.60% below its historical high of $68.55

Price 3-year low

$0.18
FGEN price is currently +54.22% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$28.01M
FGEN market capitalization is $28.01 million

Market cap 3-year change

-97.46%
FGEN market capitalization is down -97.46% over the past 3 years

Market cap All-time high

$5.66B
FGEN market capitalization is currently -99.51% below its historical high of $5.66 billion

Market cap sector rank

30.67%
FGEN market capitalization is higher than 30.67% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.45%
FGEN shares outstanding is up +1.45% year-on-year

Shares Outstanding 3-Year Change

+8.18%
FGEN shares outstanding is up +8.18% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.09
FGEN beta is 1.09

200-day SMA

$0.47
FGEN price is currently -41.30% below its 200-day simple moving average

50-day SMA

$0.40
FGEN price is currently -31.27% below its 50-day simple moving average

RSI

40.11
FGEN 14-day relative strength index is 40.11

Volume

0.33
FGEN 30-day relative volume is 0.33

ATR

$0.04
FGEN average true range is $0.04

10-day Historical Volatility

86.78%
FGEN 10-day historical volatility is 86.78%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$29.62M
FGEN annual revenue is $29.62 million

Revenue Analysts estimate

$96.65M
FGEN annual revenue is currently -69.35% lower than the consensus analysts' forecast

Revenue 1-year change

-36.71%
FGEN annual revenue is down -36.71% year-on-year

Revenue Sector rank

39.22%
FGEN annual revenue is higher than 39.22% of companies in Healthcare sector

EPS

EPS

-$0.48
FGEN annual earnings per share is -$0.48

EPS Analysts estimate

-$0.70
FGEN annual earnings per share is currently -31.91% lower than the consensus analysts' forecast

EPS 1-year change

+83.56%
FGEN annual earnings per share is up +83.56% year-on-year

EPS Sector rank

69.51%
FGEN annual earnings per share is higher than 69.51% of companies in Healthcare sector

Profit

Gross profit

$14.06M
FGEN annual gross profit is $14.06 million

Gross margin

47.47%
FGEN annual gross profit margin is 47.47%

Operating profit

-$130.96M
FGEN annual operating income is -$130.96 million

Operating margin

-442.13%
FGEN annual operating profit margin is -442.13%

Net income

-$47.58M
FGEN annual net profit is -$47.58 million

Net margin

-160.63%
FGEN annual net profit margin is -160.63%

Expenses

Total expenses

$160.58M
FGEN annual total expenses is $160.58 million

Operating expenses

$145.02M
FGEN annual total operating expenses is $145.02 million

Cost of goods sold

$15.56M
FGEN annual cost of goods sold is $15.56 million

Selling, general & administrative expenses

$49.33M
FGEN annual SGA is $49.33 million

Depreciation and amortization

$2.69M
FGEN annual depreciation & amortization is $2.69 million

Interest expense

$8.25M
FGEN annual interest expense is $8.25 million

Income tax

-$269.00K
FGEN annual income tax is -$269.00 thousand

EBIT & EBITDA

EBIT

-$145.12M
FGEN annual earnings before interest & taxes is -$145.12 million

EBITDA

-$142.43M
FGEN annual EBITDA is -$142.43 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$214.53M
FGEN annual total assets is $214.53 million

Non current assets

$18.02M
FGEN annual long term assets is $18.02 million

Current assets

$196.51M
FGEN annual total current assets is $196.51 million

Cash and cash equivalents

$50.48M
FGEN annual cash & cash equivalents is $50.48 million

Accounts receivable

$481.00K
FGEN annual accounts receivable is $481.00 thousand

Inventory

$3.15M
FGEN annual inventory is $3.15 million

Liabilities

Total liabilities

$398.16M
FGEN annual total liabilities is $398.16 million

Long term liabilities

$264.85M
FGEN annual total long term liabilities is $264.85 million

Current liabilities

$133.31M
FGEN annual total current liabilities is $133.31 million

Accounts payable

$5.06M
FGEN annual accounts payable is $5.06 million

Debt

Total debt

$73.09M
FGEN annual total debt is $73.09 million

Total debt 1-year change

-51.15%
FGEN annual total debt is down -51.15% year-on-year

Long term debt

$73.09M
FGEN annual long term debt is $73.09 million

Short term debt

$0.00
FGEN annual short term debt is $0.00

Equity & Capital

Shareholders equity

-$225.60M
FGEN annual stockholders equity is -$225.60 million

Book value

-$225.60M
FGEN annual book value is -$225.60 million

Retained earnings

-$1.89B
FGEN annual retained earnings is -$1.89 billion

Working capital

$63.20M
FGEN annual working capital is $63.20 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$138.00M
FGEN annual cash flow from operations is -$138.00 million

Cash from operations 1-year change

+56.19%
FGEN annual cash flow from operations is up +56.19% year-on-year

Cash from investing

$125.99M
FGEN annual cash flow from investing activities is $125.99 million

Cash from investing 1-year change

-18%
FGEN annual cash flow from investing activities is down -18% year-on-year

Cash from financing

-$255.00K
FGEN annual cash flow from financing activities is -$255.00 thousand

Cash from financing 1-year change

-100.21%
FGEN annual cash flow from financing activities is down -100.21% year-on-year

CAPEX

CAPEX

$266.00K
FGEN annual capital expenditures is $266.00 thousand

CAPEX 1-year change

-89.44%
FGEN annual capital expenditures is down -89.44% year-on-year

Free Cash Flow

Free cash flow

-$138.26M
FGEN annual free cash flow is -$138.26 million

Free cash flow 1-year change

+56.46%
FGEN annual free cash flow is up +56.46% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

47.47%
FGEN annual gross profit margin is 47.47%

Operating margin

-442.13%
FGEN annual operating profit margin is -442.13%

Net margin

-160.63%
FGEN annual net profit margin is -160.63%

ROA & ROE

ROA

-14.91%
FGEN annual return on assets is -14.91%

ROE

21.09%
FGEN annual return on equity is 21.09%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
FGEN price to earnings ratio value is unknown

PE ratio Sector rank

-
FGEN price to earnings ratio is unknown

PB Ratio

PB ratio

-0.12
FGEN price to book ratio is -0.12

PB ratio Sector rank

12.92%
FGEN price to book ratio is higher than 12.92% of companies in Healthcare sector

PS Ratio

PS ratio

0.95
FGEN price to sales ratio is 0.95

PS ratio Sector rank

26.92%
FGEN price to sales ratio is higher than 26.92% of companies in Healthcare sector

Enterprise value

Enterprise value

$50.62M
FGEN enterprise value is $50.62 million

Enterprise value Sector rank

41.85%
FGEN enterprise value is higher than 41.85% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.36
FGEN EV/EBITDA is -0.36

EV/EBITDA Sector rank

54.22%
FGEN EV/EBITDA is higher than 54.22% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.47
FGEN annual current ratio is 1.47

Quick ratio

1.45
FGEN annual quick ratio is 1.45

Leverage

Debt to equity

-0.32
FGEN annual debt to equity ratio is -0.32

Interest coverage ratio

-17.60
FGEN annual interest coverage ratio is -17.60

Risk & Stability

Piotroski F-Score

1
FGEN piotroski f-score is 1

Altman Z-Score

-14.03
FGEN altman z-score is -14.03

Analyst ratings

Recent major analysts updates

Mar 18, 25 HC Wainwright & Co.
Buy
Feb 20, 25 HC Wainwright & Co.
Buy
Aug 8, 23 B of A Securities
Underperform
Jun 27, 23 Raymond James
Market Perform
Jun 27, 23 Goldman Sachs
Sell
Jun 26, 23 William Blair
Market Perform
Jun 26, 23 Stifel
Hold
Jun 26, 23 Raymond James
Market Perform
Jun 26, 23 B of A Securities
Neutral
Jun 2, 23 Stifel
Buy

Institutional Ownership

Similar stocks

PYPD logo
PolyPid (PYPD)
Grace Therapeutics (GRCE)
INTS logo
Intensity Therapeutics (INTS)
ALGS logo
Aligos Therapeutics (ALGS)
COCH logo
Envoy Medical (COCH)
CLGN logo
CollPlant Biotechnologies (CLGN)
BRNS logo
Barinthus Biotherapeutics (BRNS)
VYNE logo
VYNE Therapeutics (VYNE)
LSB logo
LakeShore Biopharma Co Ltd (LSB)
  • What is the ticker symbol for FibroGen?
  • Does FibroGen pay dividends?
  • What sector is FibroGen in?
  • What industry is FibroGen in?
  • What country is FibroGen based in?
  • When did FibroGen go public?
  • Is FibroGen in the S&P 500?
  • Is FibroGen in the NASDAQ 100?
  • Is FibroGen in the Dow Jones?
  • When was FibroGen's last earnings report?
  • When does FibroGen report earnings?
  • Should I buy FibroGen stock now?

What is the ticker symbol for FibroGen?

The ticker symbol for FibroGen is NASDAQ:FGEN

Does FibroGen pay dividends?

No, FibroGen does not pay dividends

What sector is FibroGen in?

FibroGen is in the Healthcare sector

What industry is FibroGen in?

FibroGen is in the Biotechnology industry

What country is FibroGen based in?

FibroGen is headquartered in United States

When did FibroGen go public?

FibroGen's initial public offering (IPO) was on November 14, 2014

Is FibroGen in the S&P 500?

No, FibroGen is not included in the S&P 500 index

Is FibroGen in the NASDAQ 100?

No, FibroGen is not included in the NASDAQ 100 index

Is FibroGen in the Dow Jones?

No, FibroGen is not included in the Dow Jones index

When was FibroGen's last earnings report?

FibroGen's most recent earnings report was on Mar 17, 2025

When does FibroGen report earnings?

The next expected earnings date for FibroGen is May 6, 2025

Should I buy FibroGen stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page